Compare Stocks → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:BCATNASDAQ:HYLSNASDAQ:KBWBNYSE:KDMN Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBCATBlackRock Capital Allocation Term Trust$15.39-0.3%$15.79$13.67▼$16.82$1.66B0.73307,247 shs215,980 shsHYLSFirst Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF$40.23-0.3%$40.98$37.78▼$41.79$1.44B0.45186,288 shs125,770 shsKBWBInvesco KBW Bank ETF$52.49-1.1%$51.06$36.19▼$53.79$1.49B1.19901,863 shs369,385 shsKDMNKadmon$9.50$9.50$3.19▼$9.50$1.70BN/A5.11 million shs1,052 shsThe Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBCATBlackRock Capital Allocation Term Trust-0.13%+0.46%-5.39%+0.23%+4.32%HYLSFirst Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF-0.15%+0.07%-1.75%-1.94%+1.59%KBWBInvesco KBW Bank ETF+0.38%+6.27%+2.24%+7.56%+29.86%KDMNKadmon0.00%0.00%0.00%0.00%0.00%World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBCATBlackRock Capital Allocation Term TrustN/AN/AN/AN/AN/AN/AN/AN/AHYLSFirst Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETFN/AN/AN/AN/AN/AN/AN/AN/AKBWBInvesco KBW Bank ETFN/AN/AN/AN/AN/AN/AN/AN/AKDMNKadmonN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBCATBlackRock Capital Allocation Term TrustN/AN/AN/AN/AHYLSFirst Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF0.00N/AN/AN/AKBWBInvesco KBW Bank ETF0.00N/A$54.664.14% UpsideKDMNKadmonN/AN/AN/AN/ACurrent Analyst RatingsSales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBCATBlackRock Capital Allocation Term Trust$206.90M8.04N/AN/AN/A∞HYLSFirst Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETFN/AN/AN/AN/AN/AN/AKBWBInvesco KBW Bank ETFN/AN/AN/AN/AN/AN/AKDMNKadmonN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBCATBlackRock Capital Allocation Term TrustN/AN/A0.00∞N/AN/AN/AN/AN/AHYLSFirst Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETFN/AN/A0.00∞N/AN/AN/AN/AN/AKBWBInvesco KBW Bank ETFN/AN/A10.29∞N/AN/AN/AN/AN/AKDMNKadmonN/AN/A0.00∞N/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBCATBlackRock Capital Allocation Term Trust$1.539.94%+143.70%N/A1 YearsHYLSFirst Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF$2.335.79%N/AN/AN/AKBWBInvesco KBW Bank ETF$1.663.16%N/AN/AN/AKDMNKadmonN/AN/AN/AN/AN/ALatest KDMN, HYLS, BCAT, and KBWB DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/1/2024BCATBlackRock Capital Allocation Term TrustMonthly$0.12709.2%4/12/20244/15/20244/30/20244/22/2024HYLSFirst Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETFMonthly$0.21256.31%4/23/20244/24/20244/30/20243/1/2024BCATBlackRock Capital Allocation Term TrustMonthly$0.12709.72%3/14/20243/15/20243/28/20243/20/2024HYLSFirst Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETFMonthly$0.223/21/20243/22/20243/28/20243/15/2024KBWBInvesco KBW Bank ETFQuarterly$0.42653/18/20243/19/20243/22/20242/1/2024BCATBlackRock Capital Allocation Term TrustMonthly$0.12709.91%2/14/20242/15/20242/29/20242/20/2024HYLSFirst Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETFMonthly$0.22252/21/20242/22/20242/29/2024(Data available from 1/1/2013 forward)OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBCATBlackRock Capital Allocation Term Trust36.12%HYLSFirst Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETFN/AKBWBInvesco KBW Bank ETFN/AKDMNKadmonN/AInsider OwnershipCompanyInsider OwnershipBCATBlackRock Capital Allocation Term TrustN/AHYLSFirst Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETFN/AKBWBInvesco KBW Bank ETFN/AKDMNKadmonN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableBCATBlackRock Capital Allocation Term Trust147,000108.14 millionN/ANot OptionableHYLSFirst Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF147,00035.75 millionN/ANot OptionableKBWBInvesco KBW Bank ETF147,00028.30 millionN/AOptionableKDMNKadmonN/A178.52 millionN/AOptionableKDMN, HYLS, BCAT, and KBWB HeadlinesNo headlines for this company have been tracked by MarketBeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsBlackRock Capital Allocation Term TrustNYSE:BCAT-First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETFNASDAQ:HYLSThe First Trust Tactical High Yield ETF (HYLS) is an exchange-traded fund that is based on the ICE BoFA US High Yield Constrained index. The fund is an actively managed fund holding up to 130% in long positions in high yield bonds it expects to outperform, and up to 30% short positions in issues it expects to underperform. HYLS was launched on Feb 27, 2013 and is managed by First Trust.Invesco KBW Bank ETFNASDAQ:KBWBThe Invesco KBW Bank ETF (KBWB) is an exchange-traded fund that is based on the KBW Nasdaq Bank index, a modified market-cap-weighted index of US banking firms. KBWB was launched on Nov 1, 2011 and is managed by Invesco.KadmonNYSE:KDMNKadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical needs. Its clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.